Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $21.2 Million - $26.5 Million
1,858,100 Added 583.39%
2,176,600 $25.6 Million
Q4 2023

Mar 21, 2024

BUY
$9.97 - $14.52 $428,710 - $624,360
43,000 Added 15.61%
318,500 $4.52 Million
Q3 2023

Nov 13, 2023

SELL
$11.78 - $13.86 $1.45 Million - $1.71 Million
-123,423 Reduced 30.94%
275,500 $3.35 Million
Q2 2023

Aug 11, 2023

SELL
$10.72 - $13.3 $15.2 Million - $18.9 Million
-1,420,577 Reduced 78.08%
398,923 $5.01 Million
Q1 2023

May 12, 2023

SELL
$10.91 - $13.54 $1.3 Million - $1.62 Million
-119,300 Reduced 6.15%
1,819,500 $20.2 Million
Q4 2022

Feb 13, 2023

SELL
$9.89 - $12.7 $6.8 Million - $8.74 Million
-687,800 Reduced 26.19%
1,938,800 $23.7 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $8.68 Million - $11.3 Million
884,400 Added 50.76%
2,626,600 $27.4 Million
Q2 2022

Aug 11, 2022

SELL
$6.23 - $11.12 $1.14 Million - $2.04 Million
-183,700 Reduced 9.54%
1,742,200 $18.7 Million
Q1 2022

May 12, 2022

SELL
$7.89 - $12.48 $1.6 Million - $2.53 Million
-202,500 Reduced 9.51%
1,925,900 $18.2 Million
Q4 2021

Feb 11, 2022

BUY
$9.82 - $12.44 $20.3 Million - $25.7 Million
2,064,300 Added 3220.44%
2,128,400 $24.6 Million
Q3 2021

Nov 10, 2021

SELL
$8.74 - $11.84 $1.44 Million - $1.94 Million
-164,200 Reduced 71.92%
64,100 $612,000
Q2 2021

Aug 12, 2021

SELL
$8.71 - $10.72 $14.2 Million - $17.5 Million
-1,633,100 Reduced 87.74%
228,300 $2.2 Million
Q1 2021

May 13, 2021

BUY
$9.2 - $23.86 $17.1 Million - $44.4 Million
1,861,400 New
1,861,400 $18.4 Million
Q1 2020

May 13, 2020

SELL
$6.63 - $11.16 $3.22 Million - $5.43 Million
-486,200 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$7.48 - $10.75 $3.64 Million - $5.23 Million
486,200 New
486,200 $4.74 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.64B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.